In an effort to lift administrative burdens from healthcare professionals and reduce patient anxiety, B2B healthtech startup BloodGPT unveiled its AI-powered platform on June 16, 2025. The technology seeks to slash the average time doctors spend reviewing lab results from 4-7 hours per week to only 30 minutes.
BloodGPT provides solutions for both physicians and patients. Healthcare professionals receive pre-analyzed results and seamlessly integrated clinical decision support. Patients are able to view complicated data as easily understandable visualizations, along with trend tracking and personalized insights. With AI models GPT and Gemini cross-checking each other for accuracy, BloodGPT makes sure that medical knowledge and transparent reasoning back every recommendation.
Tacking a Timely Problem
With an expected deficit of 86,000 specialists in the U.S. alone by 2036, BloodGPT is positioned to be both a productivity tool for doctors and an agent of empowerment for patients.
“There are over 1 million physicians in the U.S, and, according to Stanford research, nearly half of them experience at least one symptom of burnout. Fragmented data between clinics, hospitals, and labs, together with a lack of historical context, make it increasingly difficult to deliver holistic patient care and force doctors to spend more time on administrative tasks. With growing pressure on healthcare systems and a push toward automation in diagnostics, the timing is ideal to position BloodGPT as an augmentation tool that saves time, reduces error, and scales access,” says Nikita Udovichenko, BloodGPT Co-founder.
User Experience Reimagined
Patients using BloodGPT receive near-immediate feedback on their blood tests, including historical data tracking and tailored health recommendations. The platform swaps PDFs and jargon-heavy reports for a gamified, interactive experience. On the physician side, BloodGPT reduces the need for follow-up questions and documentation, and allows doctors more time to focus on complex medical work. Healthcare professionals have the option of using BloodGPT for diagnostics and treatment plan development — in this case, the journey takes three minutes.
“Around 14 billion lab tests are performed in the U.S. each year. Everybody has experienced frustration in receiving results from their doctor. They come in a one-dimensional flat PDF, often scribbled on with illegible comments, using terms that are inaccessible to the layperson. There is no effective ability to compare these results to previous ones to get a better understanding of your health trends. BloodGPT addresses all these frustrations in a friendly way, at a time when taking responsibility for your own health is becoming increasingly essential,” says Jonathan Kron, BloodGPT strategic adviser.
A Seasoned Team
The BloodGPT team brings together decades of clinical, technical, and entrepreneurial experience. Co-founder & CEO Vasilii Lazuka is an entrepreneur with a successful 8-digit exit in enterprise software. Co-founder & CMO Nikita Udovichenko, a biochemist and seasoned founder, possesses deep expertise in endocrinology. Head of Product Nata Savaścienka has a strong background in enterprise AI software and products. Jonathan Kron is a strategic adviser for healthcare executives & owners.
